Cure My Disease

Don't miss your cure!

 Log in / Sign up

Stool DNA test may offer easier cancer monitoring

NCT ID NCT04624555

Recruiting now Diagnosis Sponsor: Case Comprehensive Cancer Center Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether a stool DNA test (mt-sDNA) can accurately detect polyps or cancer in people who have already been treated for stage I-III colorectal cancer. Researchers will compare the stool test results to colonoscopy findings in 50 survivors. The goal is to see if the stool test is a reliable and acceptable alternative for routine surveillance.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Multi-target stool DNA (mt-sDNA) test
What this could lead to
If successful, this stool test could offer a less invasive way to monitor colorectal cancer survivors for recurrence, potentially reducing the need for frequent colonoscopies.
What could go wrong
This is a small early study with only 50 participants, so results may not apply to everyone. The stool test may miss some polyps or cancers, leading to false reassurance.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ADENOCARCINOMA OF THE COLON are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

colon adenocarcinoma colonic neoplasm colorectal cancer colorectal carcinoma colorectal neoplasm rectal neoplasm rectum adenocarcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ADENOCARCINOMA OF THE COLON ADENOCARCINOMA OF THE RECTUM STAGE I COLORECTAL CANCER STAGE II COLORECTAL CANCER STAGE III COLORECTAL CANCER

Contacts and locations

Locations

  • University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center

    RECRUITING

    Cleveland, Ohio, 44106, United States

    Contact Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.